期刊文献+

RET基因功能性单核苷酸多态与先天性巨结肠风险

Associations between genetic polymorphisms in RET and risk of Hirschsprung′s disease in a Chinese population
下载PDF
导出
摘要 目的先天性巨结肠是一种肠神经系统发育异常导致的先天性消化道畸形。RET基因是其主要致病基因,本研究探讨RET启动子区的两个功能性单核苷酸多态?5G/A和?1A/C与先天性巨结肠遗传易感性的关系。方法以聚合酶链反应(PCR)和直接测序(d irect-squenc ing)分析方法,检测了52例先天性巨结肠病人和120例正常对照者RET?5G/A和?1A/C的基因型,比较不同基因型与先天性巨结肠风险的相关性。结果RET?5AA和?1CC基因型频率在先天性巨结肠患者和正常对照中的分布有显著性差异(P值分别为<0.001和0.003),携带RET?5AA和?1CC基因型者罹患先天性巨结肠的风险分别是携带RET?5GG和?1AA基因型者的11.40倍(95%C I,2.89?53.09)和4.65倍(95%C I,0.98?32.30)。此外,单倍型分析发现,同时携带两种风险等位基因的A—C单倍型者的患病风险比携带G—A型者增高了4.38倍(95%C I,2.53?11.90)。结论RET基因功能性单核苷酸多态?5G/A和?1A/C多态可能是中国人先天性巨结肠的遗传易感因素。 Objective: Hirschsprung's disease (HSCR) is a congenital disorder characterized by an absence of ganglion cells in the nerve plexuses of the lower digestive tract. The major HSCR gene is the receptor tyrosine kinase RET, in which the promoter polymorphisms- 5G/A and -1A/C were identified to be functional. This case- control study examined the contribution of these polymorphisms to susceptibility of HSCR. Methods: Genotypes were determined in 52 patients with HSCR and 120 normal controls. The adjusted odds ratios (ORs) and 95% confidence intervals (Cls) were calculated using logistic regression model. Results : We found a significantly increased risk of HSCR associated with homozygous genotypes of the RET 5AA or RET 1CC compared with the RET - 5GG (OR = 11.40,95% CI,2.89 - 53.09) or RET - 1AA (OR= 4.65, 95% CI, 0.98 - 32. 30) genotypes, respectively. Furthermore, haplotypes analysis indicated that the A-C haplotype increases the risk of HSCR compared with G-A haplotype. Conclusion: These findings suggest that RET functional polymorphisms - 5G/A and - 1A/C may be genetic susceptibility factors for HSCR among Chinese.
出处 《中国优生与遗传杂志》 2006年第12期22-23,89,共3页 Chinese Journal of Birth Health & Heredity
关键词 先天性巨结肠 RET 基因单核苷酸多态 分子遗传学 Hirschsprung's disease RET Polymorphism Molecular genetics
  • 相关文献

参考文献9

  • 1Amiel J,Lyonnet S.Hirschsprung disease,associated syndromes,and genetics:a review[J].J Med Genet,2001,38:729-39.
  • 2Brooks AS,Oostra BA,Hofstra RM.Studying the genetics of Hirschsprung's disease:unraveling an oligogenic disorder[J].Clin Genet,2005,67:6-14.
  • 3Angrist M,Kauffman E,Slaugenhaupt SA,et al.A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10[J].Nat Genet,1993,4:351-6.
  • 4Garcia-Barcelo M,Ganster RW,Lui VC,et al.TTF-1 and RET promoter SNPs:regulation of RET transcription in Hirschsprung′s disease[J].Hum Mol Genet 2005,14:191-204.
  • 5Scheet P,Stephens M.A fast and flexible statistical model for large-scale population genotype data:applications to inferring missing genotypes and haplotypic phase[J].Am J Hum Genet,2006,78:629-464.
  • 6Micci MA,Learish RD,Li H,et al.Neural stem cells express RET,produce nitric oxide,and survive transplantation in the gastrointestinal tract[J].Gastroenterology,2001,121(4):757-766.
  • 7Iwashita T,Kruger GM,Pardal R,Kiel MJ,Morrison SJ.Hirschsprung disease is linked to defects in neural crest stem cell function[J].Science,2003,301:972-6.
  • 8Attie T,Pelet A,Edery P,et al.Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease[J].Hum Mol Genet,1995,4:1381-6.
  • 9王国斌,杜寒松,张颖,陶凯雄,牛彦锋,魏明发,汤绍涛.中国汉族人群RET基因多态性与先天性巨结肠的遗传易感性研究[J].中华小儿外科杂志,2005,26(12):627-630. 被引量:5

二级参考文献10

  • 1Fitze G,Schreiber M,Kuhlisch E,et al. Association of the RET proto-oncogene codon 45 polymorphism with Hirschsprung disease. Am J Hum Genet,1999,65:1469-1473.
  • 2Borrego S,Saez ME,Ruiz A,et al. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet,1999,36: 771-774.
  • 3Bolk S,Pelet A,Hofstra R,et al. A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci USA,2000,97:268-273.
  • 4Mulligan LM,Kwok JBJ,Healey CS,et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature,1993,363:458-460.
  • 5Ceccherini I,Hofstra RMW,Luo Y. DNA polymorphism and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene,1994,9:3025-3029.
  • 6Saez ME,S nchez B,Antinolo G,et al. Identification of a rare polymorphism,S836S,in the tyrosine kinase domain of RET proto-oncogene. Hum Mutat,1998,11:416-416.
  • 7Gimm O,Neuberg DS,Marsh DJ,et al. Over-representation of germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene,1999,18: 1369-1373.
  • 8Fitze G,Cramer J,Ziegler A,et al. Association between c135G/A genotype and RET proto-oncogene germline mutation and phenotype of Hirschsprung's disease. Lancet,2002,359:1200-1205.
  • 9Guido Fitze,Hella Appelt,Inke R. Knig,et al. Schackert Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease(HSCR). Hum Mol Genet,2003,12: 3207-3214.
  • 10M Sancandi,P Griseri,B Pesce,et al. Single nucleotide polymorphic alleles in the 5' region of the RET proto-oncogene define a risk haplotype in Hirschsprung's disease. J Med Genet,2003,40: 714-718.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部